American Cancer Society. Key statistics in prostate cancer. Accessed December 11, 2021. Available at: https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html
Heijnsdijk EA, Wever EM, Auvinen A, et al. Quality-of-life effects of prostate-specific antigen screening. N Engl J Med 2012;367:595–605.
Desch CE, McNiff KK, Schneider EC, et al. American Society of Clinical Oncology/National Comprehensive Cancer Network quality measures. J Clin Oncol 2008;26:3631–3637.
Schaeffer EM, Srinivas S, An Y, et al. NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer. Version 1.2023. Accessed July 23, 2022. To view the most recent version, visit https://www.nccn.org
Moses KA, Sprenkle PC, Box G, et al. NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer Early Detection. Version 1.2022. Accessed July 23, 2022. To view the most recent version, visit https://www.nccn.org
Ricci-Cabello I, Vásquez-Mejía A, Canelo-Aybar C, et al. Adherence to breast cancer guidelines is associated with better survival outcomes: a systematic review and meta-analysis of observational studies in EU countries. BMC Health Serv Res 2020;20:920.
- Search Google Scholar
- Export Citation
, Ricci-Cabello I , Vásquez-Mejía A , Canelo-Aybar C Adherence to breast cancer guidelines is associated with better survival outcomes: a systematic review and meta-analysis of observational studies in EU countries. BMC Health Serv Res 2020; 20: 920. 33028324
Worhunsky DJ, Ma Y, Zak Y, et al. Compliance with gastric cancer guidelines is associated with improved outcomes. J Natl Compr Canc Netw 2015;13:319–325.
Lopez-Olivo MA, Maki KG, Choi NJ, et al. Patient adherence to screening for lung cancer in the US: a systematic review and meta-analysis. JAMA Netw Open 2020;3:e2025102.
Chamie K, Saigal CS, Lai J, et al. Compliance with guidelines for patients with bladder cancer: variation in the delivery of care. Cancer 2011;117:5392–5401.
Mackay TM, Latenstein AEJ, Bonsing BA, et al. Nationwide compliance with a multidisciplinary guideline on pancreatic cancer during 6-year follow-up. Pancreatology 2020;20:1723–1731.
Thibault C, Fizazi K, Barrios D, et al. Compliance with guidelines and correlation with outcome in patients with advanced germ-cell tumours. Eur J Cancer 2014;50:1284–1290.
Merkow RP, Bilimoria KY. Currently available quality improvement initiatives in surgical oncology. Surg Oncol Clin N Am 2012;21:367–375; vii.
Spinks T, Albright HW, Feeley TW, et al. Ensuring quality cancer care: a follow-up review of the Institute of Medicine’s 10 recommendations for improving the quality of cancer care in America. Cancer 2012;118:2571–2582.
Visser BC, Ma Y, Zak Y, et al. Failure to comply with NCCN Guidelines for the management of pancreatic cancer compromises outcomes. HPB (Oxford) 2012;14:539–547.
Erickson Foster J, Velasco JM, Hieken TJ. Adverse outcomes associated with noncompliance with melanoma treatment guidelines. Ann Surg Oncol 2008;15:2395–2402.
Bristow RE, Powell MA, Al-Hammadi N, et al. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status. J Natl Cancer Inst 2013;105:823–832.
Dronkers EA, Mes SW, Wieringa MH, et al. Noncompliance to guidelines in head and neck cancer treatment; associated factors for both patient and physician. BMC Cancer 2015;15:515.
Casey DE Jr. Why don’t physicians (and patients) consistently follow clinical practice guidelines? JAMA Intern Med 2013;173:1581–1583.
Ramsey SD, Cheadle AD, Neighbor WE, et al. Relative impact of patient and clinic factors on adherence to primary care preventive service guidelines: an exploratory study. Med Care 2001;39:979–989.
Mitchell JM. Urologists’ use of intensity-modulated radiation therapy for prostate cancer. N Engl J Med 2013;369:1629–1637.
Eggener SE. Recognizing and minimizing bias: helping patients make their best choice for prostate cancer management through multidisciplinary clinics. Cancer 2020;126:470–472.
Jacobs BL, Zhang Y, Skolarus TA, et al. Growth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse. Health Aff (Millwood) 2012;31:750–759.
Hillman BJ, Goldsmith J. Imaging: the self-referral boom and the ongoing search for effective policies to contain it. Health Aff (Millwood) 2010;29:2231–2236.
Mitchell JM. The prevalence of physician self-referral arrangements after Stark II: evidence from advanced diagnostic imaging. Health Aff (Millwood) 2007;26(Suppl 2):w415–424.
Li H, Zhao C, Liu P, et al. Radical prostatectomy after previous transurethral resection of the prostate: a systematic review and meta-analysis. Transl Androl Urol 2019;8:712–727.
Abdollahi A, Meysamie A, Sheikhbahaei S, et al. Inter/intra-observer reproducibility of Gleason scoring in prostate adenocarcinoma in Iranian pathologists. Urol J 2012;9:486–490.
Ozdamar SO, Sarikaya S, Yildiz L, et al. Intraobserver and interobserver reproducibility of WHO and Gleason histologic grading systems in prostatic adenocarcinomas. Int Urol Nephrol 1996;28:73–77.
McLean M, Srigley J, Banerjee D, et al. Interobserver variation in prostate cancer Gleason scoring: are there implications for the design of clinical trials and treatment strategies? Clin Oncol (R Coll Radiol) 1997;9:222–225.
Salmo EN. An audit of inter-observer variability in Gleason grading of prostate cancer biopsies: the experience of central pathology review in the North West of England. Integr Cancer Sci Ther 2015;2:104–106.
Montironi R, Lopez-Beltran A, Cheng L, et al. Central prostate pathology review: should it be mandatory? Eur Urol 2013;64:199–201; discussion 202–203.